Pharma Capital
EPIC: DDDD
Market: AIM
52-week High/Low: 819.50p / 220.05p
Sector: Pharma & Biotech
Market Cap: 235.29M

4d pharma plc is a pharmaceutical company focussing on developing a number of projects targeting important new therapeutic areas.

Interactive graph

col 3
col 4
col 5
col 6

4D Pharma Timeline

Newswire

4D restarts Thetanix phase I trials

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.